Skip to main content
Search

# Ruby

1 related articles

Subscribe to updates
  1. Ruby predicts potency without drawing a binding pose: at 25 ms per ligand it edges out Boltz-2 running 1,250 times slower

    In drug discovery, free-energy methods are accurate but too costly and ligand-based QSAR is cheap but fails to generalize to new scaffolds, so computational routes tend to cover either screening or lead optimization. Ruby predicts potency directly from the protein-ligand pair representation of the cofolding model Pearl, without generating an explicit binding pose, and one checkpoint runs at four inference-effort settings. On seven public screening sets, its lowest setting scores a ligand in 25 milliseconds and enriches slightly better than Boltz-2 at about 30 seconds, while the Max setting at 4 seconds per ligand roughly doubles enrichment to 0.43.

You’re all caught up